Search for: "Regeneron" Results 41 - 60 of 223
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Nov 2021, 8:20 am by Lisa Larrimore Ouellette
As a comparison, the average cost of COVID-19 hospitalization is around $20,000, and Regeneron’s antibody cocktail can cost $2,000 for the drug and infusion. [read post]
18 Sep 2021, 8:45 pm by Patent Docs
The program will consist of two panels: • Panel I -- Current Topics in the Federal Circuit’s Law of Written Description and Enablement -- John Josef Molenda of Steptoe & Johnson LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Henry Hadad of Bristol-Myers Squibb; Joshua Rosenkranz of Orrick, Herrington & Sutcliffe LLP; and John Whealan of The George Washington... [read post]
17 Sep 2021, 4:15 am by Jonathan Stroud
An average week saw 54 district court patent filings and 30 Patent Trial and Appeal Board (PTAB) petitions, the majority of the latter being associated with semiconductor litigation. [read post]
17 Sep 2021, 4:15 am by Jonathan Stroud
An average week saw 54 district court patent filings and 30 Patent Trial and Appeal Board (PTAB) petitions, the majority of the latter being associated with semiconductor litigation. [read post]
14 Sep 2021, 6:47 am by Erica Blachman Hitchings
”  Here again, Judge Gorton could build upon the opinion in the Regeneron suit. [read post]
The UK position on such claims was most recently set out by Kitchin LJ (as he then was) in Regeneron v Genentech [2013] EWCA Civ 93: “it is permissible to define an invention using general terms provided the patent discloses a principle of general application in the sense that it can reasonably be expected the invention will work with anything falling within the scope of these terms”. [read post]
20 Aug 2021, 4:00 am by Jim Sedor
National/Federal As Population Grows, So Does Debate on How to Reach Latino Voters in ’22 Midterms MSN – Stephanie Akin and Suzanne Monyak (Roll Call) | Published: 8/18/2021 Democrats know that, overall, the party does better with Latino voters than Republicans, but there is more recognition that the Hispanic electorate is far from monolithic, and outreach needs to start much earlier. [read post]
26 Jul 2021, 9:10 pm by Joshua Burd
For instance, political pressure from the White House in 2020 to support hydroxychloroquine, convalescent plasma, Regeneron’s antibody therapy, and vaccines made legitimate evaluation of scientific evidence more challenging. [read post]
26 Jun 2021, 2:59 am by Annsley Merelle Ward
The AmeriKat looking towardsa future of the Formstein defence from her own kitchen sinkIs Instagram Live actually live? [read post]
15 Jun 2021, 9:02 am by Beth Mole
That list includes the CEOs of Regeneron ($174 million), Eli Lilly ($68 million), Teladoc ($45 million), UnitedHealth Group ($42 million), and Quest Diagnostics ($34 million).Read 6 remaining paragraphs | Comments [read post]
1 Jun 2021, 2:55 pm by Tom Lamb
  For a concise characterization of this latest Beovu vision loss side effects development, here is the beginning of a June 1, 2021 article by Endpoints News Senior Editor Amber Tong: Safety concerns have forced Novartis to slam the brakes on a trio of late-stage clinical studies for its eye drug Beovu, marring grand ambitions to challenge the throne currently occupied by Regeneron’s Eylea. [read post]
3 May 2021, 8:36 am by Lisa Larrimore Ouellette
The RECOVERY trial can also add arms; for example, this fall it added aspirin, colchicine, and Regeneron’s antibody cocktail. [read post]
20 Apr 2021, 4:27 am by Rob Robinson
In the last year, the company’s data under management has grown by more than 40 percent as Druva supports industry leaders, disruptors, and pioneers including GameStop, Marriott, NASA, National Cancer Institute, Pfizer, Regeneron Pharmaceuticals, and Zoom. [read post]
16 Apr 2021, 12:48 pm by Jessica R. Corpuz
  At the same time, Allele filed suit against Regeneron, the maker of an experimental antibody cocktail found to be successful in treating Covid-19 (and was famously given to President Trump just days before Allele filed suit against Regeneron). [read post]
8 Mar 2021, 1:17 am by Rose Hughes
Ilumina and Regeneron related to the question of whether all of the features in a claim must be enabled across the whole scope of the claim. [read post]
7 Mar 2021, 5:49 am by Magdaleen Jooste
The High Court decision in Illumina v MGI hit the IP headlines for its application of the Supreme Court decision in Regeneron v Kymab. [read post]
27 Feb 2021, 8:31 pm by Patent Docs
The webinar will address the following topics: • Review of key UK and EPO cases in this field • Regeneron v Kymab... [read post]
27 Feb 2021, 5:21 am by Rose Hughes
As discussed in Part 1, Regeneron (and Biogen) sufficiency requires a claim to be enabled across the entire scope of a claim (for features relating to the essence of the invention). [read post]